8.12
+0.07
+(0.87%)
As of 12:40:50 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 778.74k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ELSTON GEORGE O Chief Financial Officer | -- | Direct | -- | Jan 6, 2025 |
| LURKER NANCY S Director | -- | Direct | -- | Jan 6, 2025 |
| DUKER JAY S Chief Executive Officer | -- | Direct | -- | Jan 6, 2025 |
| LANDIS JOHN B Director | -- | Direct | -- | Jan 3, 2025 |
| ANDO GORAN A Director | Purchase at price 7.95 per share. | Direct | 39,750 | Aug 21, 2024 |
| DICICCO WENDY FRANCES Director | Purchase at price 7.79 per share. | Direct | 19,997 | Aug 20, 2024 |
| ZADEREJ KAREN L Director | Purchase at price 7.98 per share. | Direct | 99,750 | Aug 19, 2024 |
| LURKER NANCY S Director | Purchase at price 7.88 per share. | Direct | 25,003 | Aug 16, 2024 |
| GUYER DAVID R Director | Conversion of Exercise of derivative security at price 3.26 - 3.50 per share. | Direct | 32,646 | Jul 12, 2024 |
| GUYER DAVID R Director | Sale at price 10.06 per share. | Direct | 116,995 | Jul 12, 2024 |
| ZADEREJ KAREN L Director | -- | Direct | -- | Jul 11, 2024 |
| LURKER NANCY S Officer and Director | -- | Direct | -- | Jul 10, 2024 |
| DUKER JAY S Chief Executive Officer | -- | Direct | -- | Jul 10, 2024 |
| ADAMIS ANTHONY P Director | -- | Direct | -- | Jun 21, 2024 |
| GUYER DAVID R Director | Conversion of Exercise of derivative security at price 3.26 - 3.50 per share. | Direct | 32,646 | Jun 3, 2024 |
| GUYER DAVID R Director | Sale at price 10.30 per share. | Direct | 119,705 | Jun 3, 2024 |
| ELSTON GEORGE O Chief Financial Officer | -- | Direct | -- | May 24, 2024 |
| GUYER DAVID R Director | Conversion of Exercise of derivative security at price 3.26 - 3.50 per share. | Direct | 32,646 | May 14, 2024 |
| GUYER DAVID R Director | Sale at price 12.65 per share. | Direct | 147,045 | May 14, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.70 - 12.36 per share. | Indirect | 10,081,721 | May 6, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.62 - 18.90 per share. | Indirect | 10,489,446 | Apr 18, 2024 |
| PAGGIARINO DARIO A Officer | -- | Direct | -- | Mar 28, 2024 |
| DUKER JAY S Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| DUKER JAY S Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| LURKER NANCY S Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
| LURKER NANCY S Officer and Director | -- | Direct | -- | Feb 9, 2024 |
| PAGGIARINO DARIO A Officer | -- | Direct | -- | Feb 9, 2024 |
| DUKER JAY S Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| JONES DAVID SCOTT Officer | -- | Direct | -- | Feb 9, 2024 |
| ELSTON GEORGE O Chief Financial Officer | -- | Direct | -- | Feb 9, 2024 |
| JONES DAVID SCOTT Officer | Conversion of Exercise of derivative security at price 11.47 per share. | Direct | 2,397 | Feb 2, 2024 |
| JONES DAVID SCOTT Officer | Sale at price 28.49 per share. | Direct | 5,954 | Feb 2, 2024 |
| PAGGIARINO DARIO A Officer | Conversion of Exercise of derivative security at price 12.90 - 13.13 per share. | Direct | 644,047 | Jan 26, 2024 |
| JONES DAVID SCOTT Officer | Conversion of Exercise of derivative security at price 3.26 - 12.90 per share. | Direct | 177,398 | Jan 26, 2024 |
| PAGGIARINO DARIO A Officer | Sale at price 25.41 - 25.77 per share. | Direct | 1,265,539 | Jan 26, 2024 |
| JONES DAVID SCOTT Officer | Sale at price 25.27 - 25.45 per share. | Direct | 660,370 | Jan 26, 2024 |
| PAGGIARINO DARIO A Officer | Conversion of Exercise of derivative security at price 12.90 - 13.13 per share. | Direct | 7,809 | Jan 25, 2024 |
| JONES DAVID SCOTT Officer | Conversion of Exercise of derivative security at price 3.26 - 12.90 per share. | Direct | 95,670 | Jan 25, 2024 |
| PAGGIARINO DARIO A Officer | Sale at price 25.00 per share. | Direct | 15,000 | Jan 25, 2024 |
| JONES DAVID SCOTT Officer | Sale at price 25.00 - 25.01 per share. | Direct | 297,621 | Jan 25, 2024 |
| PAGGIARINO DARIO A Officer | Conversion of Exercise of derivative security at price 12.90 - 13.13 per share. | Direct | 213,379 | Jan 24, 2024 |
| LURKER NANCY S Officer and Director | Sale at price 24.97 - 24.98 per share. | Direct | 874,200 | Jan 24, 2024 |
| PAGGIARINO DARIO A Officer | Sale at price 25.00 - 25.02 per share. | Direct | 409,790 | Jan 24, 2024 |
| JONES DAVID SCOTT Officer | Conversion of Exercise of derivative security at price 3.26 - 12.90 per share. | Direct | 360,149 | Jan 23, 2024 |
| JONES DAVID SCOTT Officer | Sale at price 22.24 - 25.00 per share. | Direct | 795,191 | Jan 23, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 19.75 - 21.32 per share. | Indirect | 17,051,100 | Jan 11, 2024 |
| OCUMENSION THERAPEUTICS Director | Sale at price 19.45 per share. | Direct | 37,159,225 | Jan 11, 2024 |
| LIU YE Director | Sale at price 19.45 per share. | Indirect | 37,159,225 | Jan 11, 2024 |
| PAGGIARINO DARIO A Officer | Conversion of Exercise of derivative security at price 3.26 per share. | Direct | 74,696 | Jan 8, 2024 |
| PAGGIARINO DARIO A Officer | Sale at price 21.13 per share. | Direct | 484,124 | Jan 8, 2024 |
Related Tickers
OCUL Ocular Therapeutix, Inc.
7.89
+1.41%
FDMT 4D Molecular Therapeutics, Inc.
5.60
0.00%
RGNX REGENXBIO Inc.
8.50
+7.59%
CLSD Clearside Biomedical, Inc.
0.9350
-1.06%
DNTH Dianthus Therapeutics, Inc.
22.70
+4.27%
SCPH scPharmaceuticals Inc.
3.4500
0.00%
STOK Stoke Therapeutics, Inc.
11.66
+6.10%
ADVM Adverum Biotechnologies, Inc.
4.5150
+2.38%
GLUE Monte Rosa Therapeutics, Inc.
6.84
+6.06%
ALEC Alector, Inc.
1.7400
+1.16%